PELLICIARI, D. H. S.; REIS, C. R. A.; BORDINI, C. A. Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? – a pharmacoeconomic study. Headache Medicine, [S. l.], v. 15, n. Supplement, p. 98, 2024. Disponível em: https://headachemedicine.com.br/index.php/hm/article/view/1230. Acesso em: 21 nov. 2024.